(Q42050617)

15 October 2017

Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor (English)

1 reference

15 October 2017

Surya P Ayalasomayajula

2

1 reference

15 October 2017

Gangadhar Sunkara

1

1 reference

15 October 2017

Cheruku S Rao

3

1 reference

15 October 2017

Jonathan L Vennerstrom

4

1 reference

15 October 2017

Jack DeRuiter

5

1 reference

15 October 2017

Uday B Kompella

6

1 reference

15 October 2017

1 March 2004

1 reference

Journal of Pharmacy and Pharmacology

15 October 2017

1 reference

15 October 2017

56

1 reference

15 October 2017

3

1 reference

15 October 2017

351-358

1 reference

A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Aldose reductase inhibitors: the end of an era or the need for different trial designs?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Aldose reductase localization in human retinal mural cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Spiro hydantoin aldose reductase inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Clinical experience with sorbinil--an aldose reductase inhibitor

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

A 12-Month Randomized Controlled Study of the Aldose Reductase Inhibitor Ponalrestat in Patients with Chronic Symptomatic Diabetic Neuropathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Statistical moments in pharmacokinetics.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Basement membrane abnormalities in human eyes with diabetic retinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4469078

Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy

17 August 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Comparative studies on aldose reductase from bovine, rat and human lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Enzyme selectivity analyses of arylsulfonylamino acid aldose reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Clinical trial of an aldose reductase inhibitor in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Novel inhibitors of rat lens aldose reductase: N-[[(substituted amino)phenyl]sulfonyl]glycines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Aldose reductase inhibitors: therapeutic implications for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Inhibition of aldehyde reductase by aldose reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022908

Extracellular matrix alterations in human corneas with bullous keratopathy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15025860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Corneal re-epithelialization in galactosemic rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15025860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15025860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1211/0022357022908

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

15025860

1 reference